TCL Archive Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center December 11, 1998
TCL Archive FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma. February 17, 2006